RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy

被引:2
|
作者
Cheng, Fang [1 ]
He, Song [2 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Lab Anim Ctr, Xian 710061, Peoples R China
[2] Chongqing Med Univ, Mol Med & Tumor Res Ctr, Chongqing 400016, Peoples R China
关键词
RNA interference (RNAi); Dendritic cells (DCs); siRNA; shRNA; Immunotherapy; Specific immune responses; Vaccine; WISKOTT-ALDRICH-SYNDROME; DC-SIGN; CHEMICAL-MODIFICATION; DOWN-REGULATION; IMMUNE-SYSTEM; GENE-THERAPY; IN-VITRO; SIRNA; EXPRESSION; ANTIGEN;
D O I
10.1007/s11033-009-9789-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA interference (RNAi) is a natural process by which small interfering RNA duplex directs sequencespecific post-transcriptional silencing of homologous genes by binding to its complementary mRNA and triggering its elimination. The history of RNAi has only about two decades, however, further studies have revealed that it is a potent method of gene silencing that has developed rapidly over the past few years as a result of its extensive importance in the study of genetics, molecular biology and physiology. RNAi technology has also recently yielded significant insight into dendritic cells (DCs) by helping to elucidate numerous mechanisms that regulate the development, activation and function of cells that mediate immunity. In addition, because of its ability to suppress gene expression effectively, this technique may be used to regulate the immune response for clinical purposes. As the key antigen presenting cells, DCs play a crucial part in the start of an immune response and in the enhancement and regulation of cell mediated immune reactions. The current studies indicated that targeting DCs with RNAi is a novel and effective therapeutic method for the fundamental research, and displayed great potential in clinical treatment.
引用
收藏
页码:2635 / 2644
页数:10
相关论文
共 50 条
  • [1] RNA interference: a potent technology in studying and modulating of dendritic cells, and potential in clinical therapy
    Fang Cheng
    Song He
    Molecular Biology Reports, 2010, 37 : 2635 - 2644
  • [2] Induction of RNA interference in dendritic cells
    Mu Li
    Hua Qian
    Thomas E. Ichim
    Wei-Wen Ge
    Igor A. Popov
    Katarzyna Rycerz
    John Neu
    David White
    Robert Zhong
    Wei-Ping Min
    Immunologic Research, 2004, 30 : 215 - 230
  • [3] Induction of RNA interference in dendritic cells
    Li, M
    Qian, H
    Ichim, TE
    Ge, WW
    Popov, IA
    Rycerz, K
    Neu, J
    White, D
    Zhong, R
    Min, WP
    IMMUNOLOGIC RESEARCH, 2004, 30 (02) : 215 - 230
  • [4] Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells
    Karimi, Mohammad Hossein
    Ebadi, Padideh
    Pourfathollah, Ali Akbar
    Soheili, Zahra Soheila
    Samiee, Shahram
    Ataee, Zahra
    Tabei, Seyyed Ziyaoddin
    Moazzeni, Seyed Mohammad
    CELLULAR IMMUNOLOGY, 2009, 259 (01) : 74 - 81
  • [5] Potential use of RNA interference in cancer therapy
    Phalon, Connor
    Rao, Donald D.
    Nemunaitis, John
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2010, 12
  • [6] PLCε1: A potential target of RNA interference therapy for gastric cancer
    Yan, Fang
    Fu, Qiang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 448 (04) : 409 - 413
  • [7] Antisense RNA gene therapy for studying and modulating biological processes
    Weiss, B
    Davidkova, G
    Zhou, LW
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (03) : 334 - 358
  • [8] Mechanism of RNA interference, in vivo and potential clinical applications
    Karagiannis, TC
    El-Osta, A
    CANCER BIOLOGY & THERAPY, 2004, 3 (11) : 1069 - 1074
  • [9] Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy
    Van Brussel, Ilse
    Schrijvers, Dorien M.
    Van Vre, Emily A.
    Bult, Hidde
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5873 - 5882
  • [10] The role of transcription factors in prostate cancer and potential for future RNA interference therapy
    Fitzgerald, Kathleen A.
    Evans, James C.
    McCarthy, Joanna
    Guo, Jianfeng
    Prencipe, Maria
    Kearney, Meghan
    Watson, William R.
    O'Driscoll, Caitriona M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (06) : 633 - 649